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Immunomodulatory effects of lactic acid bacteria vary with strain and may 
vary with growth phase and medium. The ability of different lactobacilli 
strains (Lactobacillus helveticus R0052, L. rhamnosus R0011, L. 
rhamnosus GG) at different growth phases to modulate macrophage and 
intestinal epithelial cell cytokine production following a pro-inflammatory 
challenge was examined. Modulation of cytokine production by human 
macrophage cell lines (U-937) and intestinal epithelial cells (HT-29) induced 
by Tumor Necrosis Factor α was assayed by ELISA for interleukin-8 (IL-8). 
Granulocyte-macrophage colony stimulating factor (GM-CSF) production 
was assayed by ELISA in the HT-29 cell line. Strain-dependent differences 
were observed in the ability of viable bacteria and spent de Mann-Rogosa-
Sharpe (MRS) broths from log versus stationary growth phase in HT-29 and 
U-937 cells. Overall, variation in the immunomodulatory activity of these 
lactic acid bacteria and spent broths reflects not only strain variation but 
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Part 1: The Immune System 
One of the most complex biological systems in vertebrate species is the 
immune system. As organisms began to occupy unexploited evolutionary and 
ecological niches, an evolution that observed the need for further tissue 
differentiation and tissue-tissue interactions occurred. Consequently, the need 
for an organism to distinguish foreign material from its own tissue was required 
to ensure proper physiological function and viability in the context of new 
external environments. It is logical to assume that individual organisms that were 
best immunologically suited for their respective environments would go on to 
become the ancestors of modern day vertebrates, since the variation in immune 
‘tuning’ would provide a significant, unbalanced selective pressure.  Since then, 
natural selection has ‘shaped’ immune responses to be just as intricate as 
evolution has allowed other physiological and biochemical processes to become. 
Generally, vertebrate immune responses can be broken down into two 
classifications: innate and adaptive. Innate immune responses are those which 
can be considered constitutive and non-specific. Innate responses are usually 
quite basic, immediate, lack memory and have common mechanistic elements. 
For example, a bacterial infection may elicit an inflammatory response that 
utilizes part or all of a set of biochemical pathways also utilized in other types of 





al., 2008). This also illustrates why innate responses are referred to as ‘non-
specific’ (Bradley, 2008). In humans, the most common cells involved in innate 
responses to bacterial and foreign material are neutrophils, monocytes, 
macrophages and dendritic cells (Coombes and Powrie, 2008). All of the 
aforementioned cells are capable of phagocytosing and digesting foreign antigen 
in some capacity. These cells also possess other defence mechanisms such as 
the production of reactive oxygen intermediates and nitric oxide (Witthoft et al., 
1998; Korhonen et al., 2001). These products are then effective in eliminating 
invasive pathogens by causing membrane, protein and DNA (Deoxyribonucleic 
acid) damage as well as the degradation of iron-sulfur centers involved in vital 
cellular processes (Salzman et al., 1998; Bertholet et al., 1999). These defences 
are occasionally, but not necessarily, dependent on signaling from other cells 
and tissues (Witthoft et al., 1998; Korhonen et al., 2004). 
On the viral side of innate immunity, Natural Killer (NK) cells are capable 
of receiving signals from cells infected with viral material and are cytotoxic 
towards these cells despite not being required to specifically recognize Major 
Histocompatibility Complex Class 1 (MHC-1) cell surface proteins. NK cells 
produce cell-signaling molecules, known as cytokines, as well as granzymes and 
perforins involved in target-cell killing (Ward, 2004).  NK cells also possess a 
Fragment Crystallizable Receptor (FcRyIII) – a cell-surface protein that allows for 
class-specific antibody binding and allows them to carry out antibody-dependent 





molecules thus allowing NK cells to participate indirectly as an important 
component of adaptive immunity (Ward, 2004). 
As previously mentioned, many of the mechanisms involved in the 
initiation of innate immune responses are very similar. In the context of this 
thesis, the most relevant innate immune mechanism is the activation of a protein 
complex known as Nuclear Factor Kappa-Light-Chain-Enhancer of B-cells, or 
NF-κB. This complex is usually found floating freely in the cytoplasm in an 
inactivated state. There are three NF-κB subunits which are integral to end-
product transcription. These subunits are NF-κB1 p50, NF-κB2 p52 and RelA 
p65 (Perkins, 2004). In the cytoplasm, the NF-κB1 p50 is sequestered and 
inhibited by IκBα/β/ε, while the NF-κB2 p52 and RelA p65 complexes are 
sequestered in tandem with IκBα (Petrof et al., 2004). Depending on the 
dynamics of upstream signaling, ubiquitin-tagging of the IκB sequestering factor 
will result in proteosomal degradation, at which point one of the NF-κB1 p50 or 
NF-κB2 p52 will bind to RelA p65 along with a variety of other potential protein 
chaperones which are integral in allowing nuclear translocation to occur (Huxford 
et al., 1998; Perkins, 2004). Dimers of any combination of the p50, p52 or RelA 
p65 will result in the transcription of numerous genes associated with innate pro-
inflammatory responses, as well as tissue proliferation and differentiation (Suk et 
al., 2001; Yasumoto et al., 1992).  
Due to the fact that this mechanism is quite complex and there are many 
forms in which NF-κB subunits can enter the nucleus, there is a debate over the 





physiologically contradictory in similar tissues (Perkins, 2004). Despite this, there 
is a strong consensus that NF-κB activation and translocation is a convergent 
endpoint reached through many different upstream mechanisms and cascades 
within an innate-immunity context (Hong et al., 2009). Initiation of NF-κB 
translocation and activation occurs through signal transduction initiated by the 
activation of the following receptors: Tumor-Necrosis Factor (TNFR1), Toll-like 
Receptors (TLR) and Interferon-Gamma Receptor complexes (Balkwill, 2009; 











Figure 1. Generalized representation of the fundamental mechanism of NF-κB 
activation. The process can be broken down into four stages: 1) Ligand binding 
amongst a variety of ligand-specific transmembrane receptors, which activate 
signal cascades that converge upon 2) the ubiquitination of IκB complexes and 
liberation of essential protein subunits which 3) recombine to form dimers 
capable of nuclear translocation, which may result in the transcription of genes 










The adaptive immune response often interacts with the innate immune 
response and boundaries between the two types of response are not always 
clear. Adaptive immune responses often require more time and physiological 
investment to initiate as further complex intercellular signaling and processing is 
often necessary (Byrne et al., 2002). The dogmatic crux of adaptive immunity 
can be summarized in the following sequence of events: 1) antigen presentation 
by a cell capable of processing and presenting antigen on an MHC Class II 
protein. 2) Specific recognition of the MHC-antigen complex on the Antigen 
Presenting Cell (APC) and binding by T-lymphocytes, which in turn produce 
cytokines that promote B-cell proliferation and antibody production (Haller et al. 
2002) 3) Retention of small populations of specific antibody producing memory 
B-cells as a permanent adaptation against a specific antigen, providing the 
immune system with “memory”, allowing for more rapid and effective responses 
with the same antigen in subsequent encounters. Cells capable of antigen 
presentation were once thought to be limited to dendritic cells, macrophages and 
B-cells, but have now been proven to include certain epithelial tissues (Galli et 
al., 2008; Byrne et al., 2002).  
Naïve and mature T-lymphocytes are not capable of detecting 
independent antigen. Recognition is only possible after processing within APC’s. 
Although not fully understood, it is believed that T-cells evolved as an 
intermediate step in the process of antibody production to protect the organism 
from autoimmunity. This notion is further strengthened by the fact that matured 





cells. Th1 cells take part in cell-mediated adaptive immunity through the 
recruitment of immunological interceders, such as macrophages, neutrophils and 
even CD8+ T-cells.  
Some of the aforementioned interceders have the characteristic of 
producing apoptosis-inducing factors that can target infected cells. The second 
type of CD4+ T-cell, Th2, produces cytokines that promote antibody class 
switching and B-cell maturation (Cerrutti, 2008). This degree of differentiation 
into different subgroups of cells has allowed for decreased errors in the immune 
system, decreasing the likelihood of erroneous self-attack (So et al., 2008). 
Although it takes a great deal of time for these specific and lasting responses to 
be elicited in the host, the benefit of such a mechanism is beneficial - as natural 
selection has proven. 
Interestingly, most diseases in which the body recognizes its own tissues 
(in whole or in part) as foreign are the result of a failure or flaw in the adaptive 
immune response. Perhaps the best illustration of such a flaw is what we refer to 
as flesh-eating disease. In this case, bacteria such as Staphylococcus pyogenes, 
which have the ability to produce potent endotoxins, grow in human tissue (Saito 
and Miyake, 2009). Through the ability of these endotoxins to force ‘bridging’ 
between APCs and T-cells, these endotoxins stimulate excessive Th cell 
responses, which usually result in a cytokine storm that triggers an 
overwhelming, immediate response to these toxins (Saito and Miyake, 2009). 
Adding to this response is respiratory burst by neutrophils and macrophages. 





host tissues at risk of DNA damage and self-induced necrosis, and the whole 
organism is at put at risk of toxic shock (Saito and Miyake, 2009). 
The above example illustrates the point that not all pathogenic bacteria 
cause damage through exploiting or parasitizing human tissue which results in 
damage. Instead, some pathogens disrupt the immune system through more 
sophisticated mechanisms. 
It should now be quite clear how precise and intricate the mechanisms of 
both innate and adaptive immunity must be to ensure autoimmune responses do 
not occur while still allowing the host to detect invading pathogens. However, the 
immune system must also be discriminatory toward many of the endogenous 
bacteria that are encountered by the organism on a constant basis. It is with this 
in mind that the human intestinal tract is a logical model for observing the 
mechanisms and interactions of innate and adaptive immunity in humans. This 
tissue experiences continual exposure to chemical irritants, antigenic stimuli 
including food components and invasive bacteria from the external environment 
(Smith and Nagler-Anderson, 2005). Commensal bacteria have also been shown 
to inhabit these gut mucosal tissues, implying that a discriminatory factor must 
exist within both innate and adaptive immunity (Smith and Nagler-Anderson, 
2005). Improving the understanding of this miniature ecological niche is currently 







Part 2: The Intestinal Ecosystem 
 Currently, it is believed that up to 70% of the human body’s immune 
system (by mass) is in close contact and associated with intestinal tissue (Artis, 
2008). The majority of this mass can further be classified as what is known as 
MALT (Mucosa-Associated Lymphoid Tissue). Within this, another classification 
of immune tissue can be established: GALT (Gut-Associated Lymphoid Tissue) 
(Artis, 2008). Although MALT is primarily a dynamic cluster of tissues often 
associated with the gastrointestinal system, this tissue-formation is also found in 
the eyes, skin and some glands (Brandtzaeg and Pabst, 2004). This tissue is 
mainly composed of T and B lymphocytes, as well as some macrophages and 
microfold (M)-cells, which are often embedded in epithelial tissues with the 
purpose of presenting antigen to subcutaneous tissues, especially when 
amongst epithelial cells that do not possess this ability (Artis, 2008; Schulzke et 
al., 2009). Interestingly, many intestinal epithelial cells possess the ability to 
present antigen on MHCII proteins with the accompaniment of other co-
stimulatory molecules, such as CD80(B7-1) and CD86(B7-2), which improve 
adhesion between the IEC and associated T-cell (Zou and Chen, 2008).  
On a separate note, many epithelial cells in the intestine have the ability to 
secrete a variety of proteins designed for either ‘flushing’ away foreign material 
(such as the mucin family of glycosylated proteins) or for destruction of 
phagocytized bacteria in other cells through the production of  cysteine-rich β-
defensins (Mack et al., 2003; Schlee et al., 2008). Both of these characteristics 





 More specifically, GALT is composed of cell clusters that utilize both 
innate and adaptive immune responses to deal with foreign antigen. One of the 
most intriguing and complex components of the GALT are structures known as 
Peyer’s Patches – the anatomy of which has been known for years, while 
specific immune functions are still being discovered (Artis, 2008). These patches 
are located beneath intestinal epithelial tissues within the lamina propria as a 
loose connective tissue (Artis, 2008). Peyer’s Patches also have the distinction 
of being the reason for differences in the nomenclature of intestinal regions, 
where the ileum is distinguished from both the jejunum and duodenum based on 
an increasing density of patches as the intestinal tract descends (Artis, 2008). 
These patches are also useful in differentiating where the small intestine ends 
and colonic functions are observed.  
 In general, mammalian digestive tissues harbour many different types of 
bacteria and form one of the most densely populated microbial habitats in 
biology (Artis, 2008). As mentioned earlier, this environment hosts many 
environmental niches. Colonization of the intestinal tract can occur within 
minutes of mammalian birth, at which point colonizing bacteria race to exploit the 
environmental niches a newborn provides (Hrncir et al., 2008). Bacteria 
commonly found in the human digestive tract include: Eubacterium spp., 
Bifidobacterium spp., Fusobacterium spp., Peptostreptococcus spp., Escherichia 






 It is logical to assume that the benefit conferred upon any bacterial 
species inhabiting the gut is related to the provision of optimum conditions for 
growth, survival and reproduction. With the gastrointestinal tract fundamentally 
acting as an ‘internalized’ external environment, the aforementioned microbes 
are provided with warmth and a constant exposure to foods ingested by the host, 
which may or may not be exploited by the bacteria. However, with this in mind, 
one must ask the reciprocate question: What benefit do the bacteria confer upon 
the host? Although digestion can occur across intestinal tissues in the absence 
of the normal gut flora, mice-models produced with the goal of absolute intestinal 
sterility (‘germ-free’) have consistently been shown to have difficulty in 
developing the same immune tissues and physiology associated with wild-type 
(control) organisms (Hrncir et al., 2008).  
The mechanisms behind this vast developmental discrepancy have been 
investigated and debated for many years now, and from this a variety of  new 
questions have arisen. Many have pondered what other effects these 
populations of organisms, in whole or in part, have on fully developed hosts in 
other contexts (such as infection, for example). For the most part, the research 
and development that goes into answering questions surrounding the host 
microflora and its beneficial effects on the immune system have been draped in 
a field broadly referred to as ‘probiotics’, which is derived from the Latin 
language, meaning ‘for life’ (Lilley and Stillwell, 1965). This is in clear reference 
to the biotechnological potential for using or modifying the host microflora to 





variables surrounding the activity and processes of the normal gut flora, 
scientists and researchers are struggling with the single most fundamental 
question that encompasses the entire field: What defines a “probiotic”? 
 
Part 3: Probiotics and Biomarkers 
 Many definitions of a probiotic have developed throughout the second half 
of the 20th Century. The definitions have concerned specific bacterial strains, 
viability, quantity and benefits conferred (Sanders, 2008).  The most widely 
accepted definition of probiotics is currently employed through an emphasis on 
the manipulation or alteration of the natural microflora (Defined by the Food and 
Agriculture Organization and the World Health Organization as “live organisms 
that when administered in adequate amounts confer a health benefit on the 
host”) (FAO and WHO, 2002). Unfortunately, according to this definition the use 
of the “probiotic” term now hinges on what is considered a health benefit. To this 
end, some in the community of probiotic research have very liberal definitions of 
a probiotic effect, while many others will not concede the title of ‘probiotic’ upon 
an organism until an overwhelming number of perceived health benefits have 
been proven specific to the respective organism. 
 Dependent on the standardization of a definition probiotics is the 
emerging field of ‘prebiotics’, which can be defined as “nondigestible substances 
that provide a beneficial physiological effect on the host by selectively stimulating 
the favorable growth or activity of a limited number indigenous bacteria” (Reid, 





definition seems tied to physiological effects, which in and of themselves may or 
may not necessarily be responsible for beneficial health effects. 
 Some of the beneficial health effects that have been generally accepted 
as well established within the probiotic field, according to de Vrese and 
Schrezenmeir (2008) are: a) a reduction in antibiotic induced diarrhea; b) a 
reduction in the concentration of cancer-promoting enzymes and putrefactive 
enzymes in the gut; c) an alleviation of inflammatory diseases and H. pylori 
infections and d) a prevention of allergies and infections. 
 Since most of the beneficial health effects claimed attributable to any so-
called probiotic have a basis in cell biology and immunology, it is the instruments 
of these fields that provide the basis for studying these effects (Reid and Burton, 
2002). The fields of cell biology and immunology are both reliant on the use of 
biomarkers. Effective biomarkers are those molecules which are indicative of 
some condition and specific to only that condition and very few others (Lebeer et 
al., 2008; Johnson-Henry et al., 2004). This has been an effective method for 
gaining an improved knowledge of cellular signaling and extracellular events. In 
other contexts, such as molecular biology, genome-wide microarrays are 
capable of taking instantaneous gene-expression ‘snap-shots’ (Peterson et al., 
2008). Unfortunately, as many intracellular and extracellular pathways are 
currently too complex to instantaneously map or trace in their entirety at the 
enzymatic level, select markers from these pathways are taken and used as 
indicative of the involvement of those pathways in specific conditions (Peterson 





In a purely immunological sense, many biomarkers have been selected as 
indicative of specific conditions. The best practical example of a biomarker is a 
Human Immunodeficiency Virus (HIV) test, whereby the standalone virions are 
not the target of detection. Instead, a rise in HIV-specific antibodies by the host is 
used to indicate infection (Kwong and Wilson, 2009). In much the same way, 
biomarkers traditionally used in pure immunological studies are of primary 
importance in probiotic studies, and there have recently been many studies 
conducted on many of these biomarkers (Cross et al., 2004). These studies are 
conducted in the same manner as many pure immunological studies: through 
animal models and isolated cell culture. 
 
Part 4: Immunological Research Investigating Probiotic Bioactivity and 
Immunomodulation 
 
Section A: Empirical Evidence of Probiotic Modulation of Innate Immunity 
 The most common model systems in the field of probiotic and 
immunological research are in vitro cell culture and in situ animal studies. In the 
former, a standardized cell line is established from a sample tissue that is taken 
from a transformed tissue sample. The deregulation of cell cycle control allows 
for these cells to be easily used in culture and to establish permanent cell lines. 
For example, the HT-29 intestinal epithelial cell line was derived from glandular 





with a hematological malignancy (Sundstrom and Nilsson, 1976; Chen et al., 
1987). The U-937 cell line can be further differentiated into a more mature 
macrophage stage using PMA (phorbol 12-myristate 13-acetate), Interferon-
gamma or vitamin D (Kitamura et al., 2004).  
Although these models are simple, they provide a ‘first step’ in evaluating 
the probable effect of an antigen, growth factor or other stimulant before moving 
to more complex and costly models. Interestingly, tissue culture has existed 
since the early 1900’s and has since provided the basis for one of the most 
significant events in biotechnological history: the discovery of hybridomas and 
monoclonal antibody production. 
  It is important to consider the fact that many of the biomarkers 
currently used in immunological research have multiple roles which are often 
conflicting between different tissues and cell types. An excellent example of this 
is provided by the cytokine Tumour Necrosis Factor-α (TNFα), which not only 
acts as an excellent challenge/inducer of NF-kB activation, but it was originally 
discovered as possessing potent tumour cytotoxicity in earlier animal models 
(Bradley, 2008).  
Investigations into probiotic activity have also complicated the notion that 
commensal bacteria are only beneficial to the health of the host. This is best 
exemplified by the reporting of NF-kB pathway induction by L. casei, given the 
pro-inflammatory context of the upregulated biomarkers (Kim et al., 2006). 





inhibition of IEC NF-kB activation by gut commensals has been suggested as a 
mechanism for preventing excessive inflammatory responses to commensal 
microflora (Neish et al., 2000; Riedel et al., 2006; Borruel et al., 2003). 
 In general, most gram-positive Lactobacilli are believed to be neutral 
organisms in the human gut, if not conferring some immunomodulatory health 
benefit (Vizoso Pinto et al., 2007). However, this is not necessarily true. When 
introduced to the blood stream, numerous Lactobacilli strains have been shown 
to cause endocarditis, a chronic active infection of the heart (Amrikachi et al., 
1997). This not only illustrates that the term ‘probiotic’ is context-dependent, but 
also that the regulation of the microflora in the gut is of extreme importance given 
its proximity to the bloodstream, as utilized in normal digestive functions. This 
also introduces a cautionary note regarding the use of probiotics in certain 
therapeutic applications where there is risk of spread via the bloodstream 
(Hessle et al., 1999). 
 Of particular interest in probiotic immunology is the mechanism and 
degree of gastrointestinal adhesion by commensal bacteria, and whether or not 
this adhesion or other biological effects are dependent on viability. There are two 
reasons for this. First, if the mechanism of adhesion is understood, it may be 
possible to determine how this affects interactions with epithelial tissues, as well 
as other cross-talk properties. Secondly, determining whether or not a specific 
characteristic of a commensal bacterial strain is dependent on viability is 
significant in light of practical applications and commercial implications. There is 





in the gut, as the environmental stressors encountered upon oral ingestion 
change rapidly. These include changes in pH between the stomach and 
intestinal tract, the thick mucous layer covering the intestine, as well as variable 
interactions between bacterial species.  
As the degree of true gastrointestinal colonization through oral 
consumption of probiotics is controversial, the future of commensal probiotic 
foods and supplements may hinge on isolating bioactive components which are 
produced or released by these bacteria. An excellent example of this was 
provided by Ghadimi et al. (2008) in which a wide array of diverse gut-derived 
bacteria and their respective genomic DNA  were tested on the peripheral blood 
mononuclear cells of healthy subjects as well as those with chronic atopic 
dermatitis. The genomic DNA of the following bacterial strains was used: 
Lactobacillus rhamnosus GG, Lactobacillus gasseri (PA16/8), Bifidobacterium 
bifidum (MP20/5), and Bifidobacterium longum (SP07/3). Interestingly, the 
genomic DNA of each individual strain was shown to decrease the secretion of 
Dermatophagoides pteronyssinus-induced Th2 cytokines as effectively as the 
live bacteria. Although it would probably be erroneous to believe that it is solely 
the DNA of the live bacteria that is responsible for the change in cytokine profile, 
the message resulting from the experiment is clear: any single intracellular or 
extracellular component of a bacterial species able to exert some “probiotic” 






 One of the most striking examples of viability-dependent 
immunomodulation was provided by Ma et al. (2004), where viable L. reuteri was 
found to decrease TNFα-induced interleukin-8 (IL-8) expression by HT-29 IEC at 
the molecular and secretory levels. This was not the case however when the L. 
reuteri were heat killed, illustrating a requirement for viability for the 
immunomodulatory effects of this strain. IL-8 is a chemotactic cytokine 
(chemokine) which recruits macrophages and NK cells from the blood stream 
and/or Peyer’s patches into epithelial gut tissues resulting in improved antigen 
sampling (Candela et al., 2008). The IL-8 secretory response is a consequence 
of NF-kB activation, and is initiated by a variety of stimulants, including toll-like 
receptor (TLR) activation by lipopolysaccharide and teichoic acid, and cytokine 
receptor activation, such as the tumor necrosis factor receptor (TNF-R) and 
Interferon-gamma receptor (IFN-R).  Although this cytokine has long been 
associated with leukocyte recruitment and inflammation (Baggiolini et al., 1995), 
the rhodopsin-type receptors it acts upon are also affected by other chemotaxins, 
suggesting ambiguity in the current understanding of specific leukocyte 
recruitment (Baggiolini et al., 1995). 
 An improved understanding of bacterial adhesion within the intestinal 
mucosa is essential in shaping the direction of future probiotic research. Assays 
have been developed which can determine the amount of adhesion through 
fluorescence in simulated mucosal conditions. To date, one of the most 
advanced assays of intestinal bacterial adhesion was conducted by Izquierdo et 





Bifidobacterium longum strains to stomach acid and bile within porcine digestive 
mucous. The strains most effective at adhering to mucin were discovered to be 
B. longum NCC 2705 and BIF 53. However, upon treatment with lysozyme, it 
was discovered that these strains were not nearly as effective at adhering to 
mucin, thus suggesting that cell-wall components are involved in the adhesion 
mechanism (Izquierdo et al. 2008).  This supports the notion that differences in 
bacterial cell-wall hydrophobicity may be responsible for the adhesive properties 
observed in many gram positive strains (Vizoso Pinto et al. 2007).  
 Although there is still much activity in the area of cytokine profiling in the 
intestinal ecosystem, the use of co-culture systems to further mimic in vivo 
conditions is becoming more prevalent (Haller et al., 2000). The impact of 
probiotics and commensals on dendritic cells has also been the focus of recent 
research (Drakes et al., 2004).  
 
Section B: Other Approaches to Probiotic-related Immunomodulation 
 Although it may appear that most of the research investigating probiotic 
immunomodulatory activity is entirely based on bacterial:host cell interactions, 
interest in bacterial supernatant:host cell interactions has increased. Several 
recent studies have examined the effects of spent bacterial broths and media 
and analyzed them for secreted proteins, metabolites and enzymes. An example 
of this is provided by research conducted by Hoarau et al. (2008), where it was 





transduction involved in the immune functions of human dendritic cells. In this 
experiment, pathway blocking and multiple stimuli were used to determine how 
B. breve BbC50sn is capable of prolonging survival and modulating cytokine 
secretion.  
To determine the pathways involved, multiple combinations of B. breve 
BbC50sn supernatant, lipopolysaccharide and zymosan with inhibitors of p38 
mitogen activated protein kinases (MAPK), glycogen synthase kinase-3 (GSK3) 
and phosphatidylinositol 3-kinase (PI3K) pathways were tested and, IL-10 
secretion was assayed. IL-10 secretion was greatest when the PI3K pathway 
was positively involved in prolonged DC survival (as induced by BbC50sn). It 
was determined that the BbC50sn must be influencing the dendritic cells through 
a Toll-like Receptor 2 mechanism, as PI3K is one of the first pathways initiated 
through TLR2 activation. Although the identity of the TLR2 agonist released by 
BbC50 into the culture media was not determined, this study provides evidence 
for potential immunomodulation by secreted bacterial products or metabolites. 
 Another example of supernatant-based immunomodulatory investigation 
has been provided by Sougioultzis et al., (2006). In this study, it was discovered 
that Saccharomyces bouldardii (Sb) produced an anti-inflammatory factor that 
significantly inhibited NF-kB-mediated IL-8 gene and cytokine expression in HT-
29 cells stimulated by both TNFα and IL-1β. This effect was lost when the 
experiment was repeated and the Sb supernatant had been passed through a 





characterization of secreted products and factors has recently become an area 
of interest for many immunologists studying probiotics. 
Although the previous study involved a factor produced by yeast, the 
probiotic field is primarily focused on bacterial products. Expanding on the 
empirical technique employed by Sougioultzis et al., (2006) was the work of Yan 
et al., (2007). L. rhamnosus GG broth culture supernatants were ‘stripped’ of 
their soluble protein factors, which were then purified using SDS-PAGE, Western 
blot analysis and mass spectroscopy. Next, two soluble factors were isolated 
from L. rhamnosus GG media, p75 and p40.  The p75 protein was identified as a 
cell wall hydrolase, while the function of p40 is unknown despite having a close 
relation to a L. casei homolog. Isolated human and mouse colonic epithelial cells 
were independently treated with each of the two isolated proteins under TNFα 
challenge. Interestingly, Akt protein activity displayed an increase under treated 
challenge conditions relative to cells that were untreated, yet challenged. The Akt 
protein family is a set of enzymes which inhibit cytokine-mediated apoptosis 
through the activation of the PI3K pathway. This result is consistent with that of 
Hoarau et al., (2008), albeit through the use of a different genus of bacteria. Yan 
et al., (2007) also has a more direct objective in determining the properties of 
proteins secreted by L. rhamnosus GG than those utilized in Sougioultzis et al., 
(2006). Both of the aforementioned proteins, p40 and p75 were shown to protect 






More recently, the use of mass spectroscopy has become widespread 
among immunologists that have an interest in determining key molecules in 
bacterial cross-talk (Yang et al., 2007). Recently, a more comprehensive 
investigation into the identification of novel proteins secreted by L. rhamnosus 
GG was undertaken by Sanchez et al., (2009). Although many of the proteins 
previously found in media conditioned by L. rhamnosus GG are still being 
characterized for function, it was determined that cell wall hydrolases and a 
glyceraldehydes 3-phosphate dehydrogenase (GAPDH) are definitively present 
in L. rhamnosus GG-cultured media. Sanchez et al. (2009) further hypothesized 
that the extracellular GAPDH may retain enzymatic function and even play a role 
in bacterial adhesion to the intestinal epithelium. This has yet to be tested.    
The most recent literature in supernatant-based probiotic research has 
provided evidence for the possibility that immunomodulation is actually 
determined by the secretion of much simpler molecules such as short chain fatty 
acids (SCFA) (Kumar et al., 2008). It has been suggested that the ubiquitination 
of the IκB sequestering factor (which activates the transcription of pro-
inflammatory NF-κB-dependent genes) is inhibited by changes in the neddylation 
(a process analogous to ubiquitination) of cullin-1, a key player in the tagging of 
the liberation of the aforementioned sequestering factor (Kumar et al., 2008). 
However, this change is mediated by processes upstream of this step, where 
reactive oxygen species (ROS) are blocked from promoting proper neddylation 
of cullin-1 to initiate the pro-inflammatory response. This is largely due to 





butyrate and possibly other terminal products such as lactate from bacterial 
fermentations. This process is rendered a rate-limiting step, and consequently 
dictates the dynamics of NF-κB activation (Kumar et al., 2008). An intriguing 
issue arising from these findings is that SCFA are capable of freely crossing 
mammalian membranes. If SCFA are truly responsible for certain 
immunomodulatory effects of probiotics, this would either complicate the belief 
that bacterial cross-talk is intricate and tightly-regulated in conjunction with 
complex cellular mechanisms, such as NF-κB regulation, or suggest that there 
are larger, more complex physiological processes involved. 
A key and often neglected aspect related to studies of both secreted 
products from spent-culture media and whole bacterial cells is the effect of 
bacterial growth phase. Growth phase could be important in determining the root 
cause of any observed effect of probiotics. There are two plausible, non-mutually 
exclusive reasons for this. 
The first possibility concerns variables intrinsic to bacterial growth. A 
bacterial growth phase is not just an indication of the proportion of viable 
bacterial cells at any given time in the life cycle of a population. It is also a 
gradient of altered gene expression, as the enzymology of viable cells must 
change to consume waste products or secondary substrates as primary media is 
depleted (Rydzak et al., 2009). This change in enzymology and metabolites may 
yield different products not secreted at earlier growth phases, and these factors 





observed. Other fluctuating factors may also play a role, such as altered oxygen 
availability and changes in pH as cells lyse and die (Fu and Mathews, 1999).  
An example of an effect observed with respect to growth phase is 
provided by Haller et al. (1999), in which human peripheral blood monocytes 
(PBMC) were shown to produce more TNFα under stimulation when in contact 
with viable log-phase LAB strains than those that were heat-killed. However, this 
effect was reversed in the stationary phase. The authors hypothesized that these 
differences reflected changes in cell wall structure at different growth phases, 
and in the ability of viable bacteria to secrete waste products under these 
conditions (Haller et al., 1999). Another possibility could be that the stationary 
phase bacteria were secreting an immunomodulatory factor which was released 
upon heat killing. Growth phase has also been shown to alter the enzyme profile 
of pyruvate catabolism in other types of bacteria and is thus a variable that must 
not be overlooked in cross-talk research. 
The second possibility involves density-dependent effects. There is no 
doubt that the intestinal ecosystem is, literally, a biological battlefield. Many 
different species of bacteria are attempting to occupy the same ecological 
niches, and have evolved mechanisms which enable them to strive for a 
competitive advantage for survival. One of these mechanisms is known as 
Quorum Sensing (QS) which can be defined as density-dependent effects that 
result in altered gene expression, and often concern the production of 
bacteriocins or other products that give populations collective advantages over 





evolutionary benefit of quorum sensing is that it enables an all or nothing attempt 
for the population. Synergistic effects may be present in a total population as 
opposed to individual control which may be more costly on a transient, per-cell 
basis.  
The significance of QS in probiotic studies concerns the ability of 
probiotics to outcompete enterinvasive bacteria, whereby secreted bacteriocins 
or other defensive molecules may have immunomodulatory potential or decrease 
inflammatory responses (Maldonado-Barragan et al., 2009). However, cross-talk 
may not be necessary for reducing inflammatory effects, as simply decreasing 
enteroinvasive bacterial viability (due to competition) may result in a significant 
decrease in functionally effective irritants, such as LPS. However, a decrease in 
viability may also result in an increase of LPS due to lysis.       
Aside from determining what is responsible for the immunomodulatory 
effects of bacteria in the intestinal epithelium, many questions surrounding other, 
more specific variables still exist in probiotic research. Given that bacteria have 
to respond and adapt to their external environments in the same fashion as 
mammalian cells, the fluctuation of variables in probiotic models must be 
considered and incorporated into experiments.  In a separate field of 
microbiological research related to probiotics, it is important to note that 
numerous experiments investigating the effect of cytokines and foreign 
endotoxins on bacterial growth have been conducted (Kanangat et al., 1999). 
There have also been attempts to artificially create synthetic intestinal models for 





bacterial supernatants assumed to be probiotic are observed upon 
enteroinvasive strains (Medellin-Pena and Griffiths, 2009).   
There is a clear commercial benefit for discovering functional 
immunomodulatory products released by probiotics. The most significant benefit 
may be that organism viability may no longer be as much of a concern, 
especially in food products where viability decreases during storage 
(Champagne et al., 2008). As a growing area of biotechnology with practical and 
industrial potential, it only seems logical that both bacterial- and supernatant-
based approaches to probiotic research will be conducted as the field continues 
to grow and move forward. 
 
Objectives and Experimental Approach 
 The interactions between the intestinal microflora and innate immunity are 
too significant to overlook for an improved understanding of mammalian 
digestion. The intricacy of these interactions are important to note and worthy of 
research. The knowledge gained from an improved understanding of these 
interactions may be implicated in other contexts, such as chronic disease or 
bacterial function (Uronis et al., 2009).  
 The objective of this study was to compare responses in innate immunity 
between two distinct cell types: 1) IECs, using a human colorectal 
adenocarcinoma (HT-29) and 2) monocytes, using a human monocytic 
lymphoma (U-937). With an abundance of literature showing numerous strains of 





studies do not consider the fundamental mechanisms or factors that are 
responsible for these effects. Consequently, two bacterial strains, L. rhamnosus 
and L. helveticus, were tested for immunomodulatory effects which, in turn, 
would be further empirically scrutinized as both the bacteria and bacterial 
products were assessed for their isolated effects on cell lines challenged with 
TNFα.  These strains were chosen based on earlier work indicating their ability to 
influence cytokine production by IEC (Wallace et al., 2003; Wood et al., 2007).  
L. rhamnosus RO011 and L. helveticus RO052 were shown to down-regulate 
constitutive production of the pro-inflammatory cytokines IL-8 and TNFα, and 
strain RO011 also down-regulates constitutive expression of the chemokine 
RANTES and the regulatory cytokine TGFβ, by HT-29 IEC (Wallace et al., 
2003).  L. rhamnosus RO011 was also shown to down-regulate IL-8 production 
by LPS-challenged HT-29 IEC (Wood et al., 2007).  L. rhamnosus GG was also 
included as it is one of the most widely studied strains available. The effects 
upon the IEC and monocytic cell lines were indicated by the chemotactic 
cytokine IL-8 and GM-CSF biomarkers. It was hypothesized that the mechanisms 
underlying the secretion of both TNFα-induced pro-inflammatory IL-8 and 
monocyte-differentiating GM-CSF by either cell line would be influenced by the 
products secreted as a result of continued bacterial growth.  
Furthermore, it was hypothesized that the media and cells obtained during 
the stationary phase of bacterial growth (as opposed to logarithmic growth) 
would show a greater down-regulatory effect on IL-8 and GM-CSF for at least 





MATERIALS AND METHODS 
 
Cell Culture 
 The HT-29 human colorectal adenocarcinoma adherent cell line (ATCC # 
HTB-38) was obtained from the American Type Culture Collection (ATCC). HT-
29 cultures were maintained in media consisting of RPMI 1640 medium 
supplemented by 10% Fetal Bovine Serum (FBS, Sigma-Aldrich Canada) and 
0.05 mg/mL gentamicin sulphate (Sigma). Cells were grown in 250 mL, 75 cm2 
tissue culture flasks (Cellstar, Greiner Bio-One, Mississauga, Ontario). Sub-
culturing of cells was carried out every 3-4 days by rinsing the monolayers with 
Phosphate Buffered Saline (PBS) followed by incubation with 3 mL 20% trypsin 
EDTA (Sigma) diluted in RPMI 1640 at 37°C and 5% CO2 for 5 minutes. 
Adherent cells were removed by washing with RPMI 1640 media by 
centrifugation at 300 x g at 4°C for 10 minutes. The trypsin-RPMI 1640 solution 
was removed and the pellet was resuspended in 2 mL of RPMI 1640 growth 
medium for passaging or FBS-free RPMI 1640 for use in challenge-assays. Cell 
cultures were incubated in a humidified incubator (Thermo Corporation, Toronto) 
at 37°C and 5% CO2.  
 The U-937 histiocytic lymphoma suspension cell line (ATCC# CRL-
1593.2) was obtained from the American Type Culture Collection (ATCC). 
Cultures of U-937 cells were maintained in media consisting of RPMI 1640 





Pyruvate (Sigma), 1% HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid) (Sigma) and 0.05 mg/mL gentamicin sulphate (Sigma). Sub-culturing of 
cells was carried out every 3-4 days by rinsing the bottom face of the flask with 
the already-present growth media. Approximately 20% of the media in the flask 
was transferred to new flasks, at an inoculation of approximately 20% by volume. 
All other characteristics of HT-29 passaging, except for the trypsinization, were 
shared with the U-937 cell line. 
 
Preparation of Bacterial Strains  
Industrially packaged lyophilized Lactobacillus rhamnosus (strain RO011) 
and Lactobacillus helveticus (strain RO052) were obtained from Institut Rosell 
Inc. (Montreal, Quebec). Both strains were reconstituted in PBS at a 
concentration of 1 x 109 cfu/mL. Prior to culture, cells were washed by 
centrifugation at 3000 x g for 20 minutes at 4°C. The supernatant was discarded 
and the pellets were washed in PBS twice more. Lactobacillus rhamnosus GG 
(ATCC 53103) was obtained from the ATCC. The vial contents were 
resuspended in 2 mL of PBS, which was in turn dissolved in 6 mL of de Man-
Rogosa-Sharpe broth (MRS, Oxoid, United Kingdom; pH 6.2) and grown for 20 
hours. Pellets from all bacterial strains were then mixed and 19.4 mL of MRS 
broth were inoculated with 400 µL of culture and incubated in a shaking 
incubator for 20 hours at 37°C at a speed of 200-220 RPM. At 20 hours, the 





Bacterial Growth Curves 
 Bacterial growth curves were established with the use of a correlation 
between plate reader (Bio-tek Instrumentation, Nepean, Ontario) absorbance 
over a 24-hour period at a wavelength of 625 nm and MRS agar (Oxoid, United 
Kingdom; pH 6.2) plate counts. Volumes of 19.4 mL of MRS broth were 
inoculated with 400 µL of refrigerator stock bacteria and optical densities were 
taken hourly for each strain in triplicate using 96-well culture plates. Readings 
continued over a period of 24 hours. Subsequent refrigerator stocks were 
derived from established stationary phase, to a maximum of 4 passages.  
 
Preparation of Freeze-Dried Bacteria and Broths 
 Bacteria were grown in accordance with the established growth curve and 
isolated at the appropriate growth phase. Volumes of MRS broth of 98 mL were 
inoculated with 2 mL into Erlenmeyer flasks and grown to the appropriate growth 
phase, as verified by optical density. The contents of each Erlenmeyer flask were 
distributed to smaller centrifuge tubes. Bacteria were collected by centrifugation 
at 3000 x g for 20 minutes at 4°C. The broths and remaining bacterial pellets 
were removed and distributed equally into separate centrifuge tubes (half-full) 
and frozen to -80°C. Upon freezing, the tubes were placed in freeze dryer flasks 
(Thermo Corporation – ModulyoD, Toronto, Ontario). Freeze drying was carried 
out at a pressure of 30 mbar and a temperature of -50°C for 24 hours, or until full 





and bacteria were frozen at -20°C until further utilized. For media acidification 
controls, pH of unspent media was adjusted to the average of spent stationary 
phase broth (pH = 4.7). 
 
Challenge of Epithelial Cells  
 Intestinal epithelial cell HT-29’s were seeded at a concentration of 1 x 106 
cells/mL and challenged at a final concentration of 5 x 105 cells/mL at initial 
viabilities greater than 80% (as determined by a Trypan-blue exclusion count 
(Sigma-Aldrich Canada)). Cells were treated with either bacteria or broth at 
selected concentrations shortly before the introduction of challenge. Bacteria 
were washed twice in PBS and once in RPMI 1640 before being diluted in RPMI 
1640 for addition to cell cultures. All non-freeze dried broths were filtered using 
0.2 µm filters (Sigma-Aldrich). Epithelial cells were challenged for 6 hours at a 
TNFα concentration of 200 ng/mL in a humidified incubator at 37°C and 5% CO2. 
Supernatants were collected and frozen at -80°C until cytokine content was 










Challenge of Macrophages 
Monocytic U-937’s were treated and challenged with TNFα exactly the 
same as the HT-29 cell line. However, the final concentration of TNFα was 40 
ng/mL and incubation of challenge occurred for 24 hours. 
 
ELISA Quantification of IL-8 and GM-CSF 
 All buffers and reagents were produced and used in accordance with the 
manufacturer’s protocol for both IL-8 (BioSource, San Diego, California) and GM-
CSF (R&D Systems, Minneapolis, Minnesota) assays. For the IL-8 ELISA 
(Enzyme-linked Immunosorbent Assay), coating antibody was plated at a 
concentration of 1 µg/mL in coating buffer. The concentration of biotinylated anti-
IL-8 detection antibody was 0.08 µg/mL. The horseradish peroxidase (HRP)-
conjugated streptavidin was used at a 1:2500 dilution for the IL-8 assay. The 
GM-CSF coating antibody working concentration in PBS was 2.0 µg/mL. 
Detection antibody was diluted to a working concentration of 0.5 µg/mL while 
Streptavidin-HRP was diluted to 1:200. Both recombinant human IL-8 and GM-
CSF served as standards and all plates were read at a wavelength of 450 nm. 
The limit of detection for the IL-8 and GM-CSF ELISA were 12.5 pg/mL and 
15.625 pg/mL, respectively. The composition of the buffers used in each assay 







Table 1. Concentrations of each respective assay solution for both IL-8 and GM-











137 mM NaCl, 8.0 mM Na2HPO4, 1.5 
mM KH2PO4, 2.7mM KCl, pH 7.4 
 
 
Phosphate-buffered Saline (PBS) – 137 mM 
NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM 





137 mM NaCl, 8.0 mM Na2HPO4, 1.5 
mM KH2PO4, 2.7 mM KCl, 5.0g Bovine 
Serum Albumin (Fracton V), 1mL 
Tween 20, pH 7.4 
 
 
1% Bovine Serum Albumin in PBS, pH 7.2-7.4 




1.5 mM KH2PO4, 10 mM K2HPO4-3H20, 
0.4g EDTA, 0.5mL Tween 20, pH 7.4 
 
 













1.8M H2SO4 (Excess) 
 















 Data were analyzed by one-way analysis of variance (ANOVA). Results 
indicating significance (p < 0.05) were then analyzed using Tukey’s multiple 
range test for further comparison of means. Results are presented as means +/- 
standard error of the mean (S.E.M.). Each sample was run in triplicate and 
assigned an average value. Therefore, a value represented as n=1 is equivalent 



















Lactobacilli growth phases and characteristics 
 In order to determine the concentrations and pH of spent media of 
Lactobacillus rhamnosus RO011, L. helveticus RO052 and L. rhamnosus GG, a 
24-hour growth phase for each respective strain was performed (Figures 2, 3, 4). 
From these curves, distinct log and stationary growth phases were determined 
based on the consistency of absorbance, concentration and acidity (pH) of spent 
media (Table 2).  
 
Spent MRS broth does not influence baseline IL-8 secretion levels in monocytic 
U-937 cells 
 No spent broth from a specific strain or growth phase displayed a 
significant increase or decrease of baseline IL-8 secretion levels in monocytic U-
937 cells. However, a Tukey post-hoc test indicates that the MRS broth control 
(“unspent” medium) displayed a trend toward increased constitutive IL-8 
production by U-937 cells relative to all other treatments and controls, with the 







Effects of spent MRS broth on TNFα-challenged monocytic U-937 cells 
No spent broth from a specific strain or growth phase displayed a 
significant increase or decrease in IL-8 production from baseline (Figure 6). 
However, when inter-assay variation was removed by means of percent of 
control conversion, a trend toward decreased IL-8 production was observed in 
stationary phase RO011 spent broth at a 1/10 media dilution (Figure 7). The 
same property was not observed after treatment of either the RO052 (Figure 8) 
or GG (Figure 9) strains with spent MRS broths. 
 
Effects of spent MRS broth on TNFα-challenged HT-29 intestinal epithelial 
cells 
  Unchallenged HT-29 cells displayed a significant increase in IL-8 
production upon treatment with unspent MRS broth (Table 3). A significant 
reduction of IL-8 was present in TNFα-challenged cells treated with strain 
RO011, relative to all other challenge conditions, as indicated by a Tukey post-
hoc test (Figure 10). 
 
Effects of freeze-dried spent stationary RO011 broth and bacteria and acidified 
controls on TNFα-challenged U-937 monocytic macrophages  
 A significant reduction in IL-8 production was observed for U-937 cells 





in IL-8 production was observed in U-937 cells treated with freeze-dried RO011 
bacteria (Figure 11). No significant difference was observed between acidified 
media and broth controls (Figure 11). 
  
Effects of freeze-dried spent stationary RO011 broth and bacteria and acidified 
controls on TNFα-challenged HT-29 intestinal epithelial cells 
A significant reduction in IL-8 production was observed for U-937 cells 
treated with freeze-dried, spent RO011 broths (Figure 12). No significant 
difference was observed between freeze-dried stationary RO011 bacteria 
acidified media and broth controls (Figure 12).  
  
Effects of log and stationary growth phase bacteria on unchallenged and TNFα-
challenged U-937 monocytic macrophages 
 No significant difference in baseline IL-8 production was observed for any 
strain or growth phase in unchallenged U-937 cells (Figure 13). No significant 
difference in IL-8 production was observed for any strain or growth phase in 







Effects of log and stationary growth phase bacteria on unchallenged and TNFα-
challenged HT-29 intestinal epithelial cells 
No significant difference in baseline IL-8 production was observed for any 
strain or growth phase in unchallenged HT-29 cells (Figure 15). No significant 
difference in IL-8 production was observed for any strain or growth phase in 
TNFα-challenged HT-29 cells (Figure 16). A percent-control representation of the 
challenged HT-29 cells approaches trend-like status (Figure 17).  
 
Effects of freeze-dried spent stationary RO011 broth over a dilution gradient in 
TNFα-challenged HT-29 intestinal epithelial cells 
A significant threshold of detection for IL-8 production was present 
between dilutions of freeze-dried RO011 MRS broth at 12.5% and 6.25% (by 
volume) (Table 4). 
 
Effects of spent RO011 stationary broth on the production of Granulocyte 
Macrophage-Colony Stimulating Factor (GM-CSF) in HT-29 intestinal epithelial 
cells 
 Unchallenged and TNFα-challenged HT-29 cells did not produce any GM-







Figure 2. Representative growth curve for L. rhamnosus RO011 over a 24-hour 
period. The log phase occurred between the 12 and 15 hour time points (O.D. = 
0.27 - 0.42 at 625 nm). The stationary phase occurred between the 20 and 24 






























Figure 3. Representative growth curve for L. helveticus RO052 over a 24-hour 
period. The log phase occurred between the 9 and 15 hour time points (O.D. = 
0.22 - 0.42 at 625 nm). The stationary phase occurred between the 20 and 24 




























Figure 4.  Representative growth curve for L. rhamnosus GG over a 24-hour 
period. The log phase occurred between the 6 and 12 hour time points (O.D. = 
0.22 - 0.77 at 625 nm). The stationary phase occurred between the 19 and 24 


































Table 2. Quantitative information pertaining to properties of the growth phases of 
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Figure 5. Effect of spent Lactobacillus MRS broths (10% by total volume) on 
interleukin-8 production by U-937 monocytic macrophage cells (5 x 105 cells/mL) 
in the absence of TNFα following concurrent incubation. U-937 cells were 
incubated for 24 hours before supernatants were collected and assayed (data 
are shown as mean concentration in pg/mL ±SE) (One-way ANOVA; p = 0.064; n 































Figure 6. Effect of spent Lactobacillus MRS broths (10% by total volume) on 
interleukin-8 production by U-937 monocytic macrophage cells (5 x 105 cells/mL) 
in the presence of concurrent TNFα (40 ng/mL) challenge. U-937 cells were 
incubated for 24 hours before supernatants were collected and assayed (mean 
concentration in pg/mL ±SE) (One-way ANOVA; p = 0.39; n = 5 for RO011 and 





























Figure 7. IL-8 production by TNFα-challenged U-937 macrophages (TNFα at 40 
ng/mL) concurrently treated with RO011 log, RO011 stationary or unspent MRS 
broths at 1/10, 1/50 and 1/100 dilutions.  Culture supernatants were collected 24 
hrs post challenge for IL-8 measurement by ELISA.  Data are shown as mean 
(±SE) percent of TNFα-challenged control response. A trend toward decreased 
IL-8 production was observed for U-937 cells treated with stationary phase 
















































Figure 8. IL-8 production by TNFα-challenged U-937 macrophages (TNFα at 40 
ng/mL) concurrently treated with RO052 log, RO052 stationary or unspent MRS 
broths at 1/10, 1/50 and 1/100 dilutions.  Culture supernatants were 24 hrs post 
challenge for IL-8 measurement by ELISA.  Data are shown as mean (±SE) 





















































Figure 9. IL-8 production by TNFα-challenged U-937 macrophages (TNFα at 40 
ng/mL) concurrently treated with GG log, GG stationary or unspent MRS broths 
at 1/10, 1/50 and 1/100 dilutions.  Culture supernatants were 24 hrs post 
challenge for IL-8 measurement by ELISA.  Data are shown as mean (±SE) 



















































Table 3. Effect of spent Lactobacillus MRS broths (10% by volume) on 
interleukin-8 production by HT-29 intestinal epithelial cells (5 x 105 cells/mL) in 
the absence of TNFα following concurrent incubation. HT-29 cells were 
incubated for 6 hours before supernatants were collected and assayed (mean 
concentration in pg/mL ±SE). The increase in IL-8 production observed with 
unspent MRS broth was significantly different from the control and every other 
treatment shown. Asterisks denote significant difference from control (One-way 
ANOVA; p < 0.0001; n = 6). 












































Figure 10. Effect of spent Lactobacillus MRS broths (10% by total volume) on 
interleukin-8 production by TNFα-challenged HT-29 intestinal epithelial cells (5 x 
105 cells/mL) challenged with 200 ng/mL TNFα following concurrent incubation. 
IL-8 was measured 6 hours after TNFα challenge. Data are shown as mean 
concentration in pg/mL ±SE. Asterisks denote statistical significance (One-way 







































































 ±SE.  Ast


































; 10% by t








































Figure 12. Effects of acidified media broths (10% by total volume) and freeze-
dried stationary phase L. rhamnosus RO011 bacteria (5 x 106 cells/mL) and 
spent broth (0.01 g/mL; 10% by total volume) on interleukin-8 production by HT-
29 intestinal epithelial cells (5 x 105 cells/mL) in the presence of TNFα (200 
ng/mL) following concurrent incubation. IL-8 was measured 24 hours after TNFα 
challenge and data are shown as mean concentration in pg/mL ±SE. Asterisks 





















































Figure 13. Effect of three strains of Lactobacillus at both growth phases, 
separately (5 x 106 cfu/mL) on interleukin-8 production by U-937 monocytic 
macrophage cells (5 x 105 cells/mL) in the absence of TNFα following concurrent 
incubation. IL-8 was measured 24 hours after TNFα challenge and data are 






























Figure 14. Effect of three strains of Lactobacillus at both growth phases, 
separately (5 x 106 cfu/mL) on interleukin-8 production by U-937 monocytic 
macrophage cells (5 x 105 cells/mL) in the presence of TNFα (40 ng/mL) 
following concurrent incubation. IL-8 was measured 24 hours after TNFα 
challenge and data are shown as mean concentration in pg/mL ±SE (One-way 






























Figure 15. Effect of three strains of Lactobacillus at both growth phases, 
separately (5 x 106 cfu/mL) on interleukin-8 production by HT-29 intestinal 
epithelial cells (5 x 105 cells/mL) in the absence of TNFα following concurrent 
incubation. IL-8 was measured 6 hours after TNFα challenge and data are 































Figure 16. Effect of three strains of Lactobacillus at both growth phases, 
separately (5 x 106 cfu/mL) on interleukin-8 production by HT-29 intestinal 
epithelial cells (5 x 105 cells/mL) in the presence of TNFα (200 ng/mL) following 
concurrent incubation. IL-8 was measured 6 hours after TNFα challenge and 
data are shown as mean concentration in pg/mL ±SE (One-way ANOVA; p = 


































Figure 17. Effect of three strains of Lactobacillus at both growth phases, 
separately (5 x 106 cfu/mL) on interleukin-8 production by HT-29 intestinal 
epithelial cells (5 x 105 cells/mL) in the presence of TNFα (200 ng/mL) following 
concurrent incubation. IL-8 was measured 6 hours after TNFα challenge and 
data are shown as mean (±SE) percent of TNFα-challenged control response 



































Table 4. Effect of freeze-dried stationary phase L. rhamnosus RO011 broth on 
interleukin-8 production by TNFα challenged HT-29 IEC across a dilution series. 
IL-8 was measured 6 hours after TNFα challenge and data are shown as mean 
concentration in pg/mL ±SE. Asterisks denote significance (One-way ANOVA; p 
<< 0.005; n=3). 
Freeze-Dried MRS Broth 
Dilution (by Volume) 
Mean IL-8 Secretion 
(pg/mL) 
Standard Error 
0% RO011 (Challenge 
Control) 
761.93 124.79 
75% RO011 BELOW DETECTION 
LIMIT 
NOT APPLICABLE 
50% RO011 BELOW DETECTION 
LIMIT 
NOT APPLICABLE 
25% RO011 BELOW DETECTION 
LIMIT 
NOT APPLICABLE 
12.5% RO011 BELOW DETECTION 
LIMIT 
NOT APPLICABLE 
6.25% RO011* 4.50 1.94 
3.125% RO011 717.06 166.18 
1.563% RO011 796.50 195.19 
0.781% RO011 640.82 75.59 
0.391% RO011 544.10 38.59 
0.20% RO011 523.83 25.67 
0.10% RO011 552.10 47.87 
0.05% RO011 565.02 126.56 
1/10 Unspent Broth 
Dilution 
466.86 38.57 
















 Recently, the field of probiotic research has seen an increasing number of 
studies examining effects of products released into culture supernatants. 
Investigations concerning the immune responses of a specific tissue to bacterial 
growth products and cellular components are becoming as widespread as 
interactions concerning viable bacteria. At the core of most supernatant-based 
experiments is a desire to elucidate and determine the key players involved in 
bacterial cross-talk. Determining which components are responsible for the 
observed effects is often difficult in vitro due to the fact that most model systems 
are not capable of isolating synergies that occur between excluded variables that 
would otherwise exist in vivo, such as other tissue-tissue interactions. 
A common criticism of probiotic research performed in vitro often concerns 
the relevance and accuracy of variables surrounding environmental and 
physiological challenges. In the context of this thesis, the primary challenge, 
TNFα, is pleiotropically characteristic of numerous autoimmune intestinal 
diseases. Specifically, an excess of TNFα production is a hallmark of Crohn’s 
disease and a property of intermittent ulcerative colitis (Cho, 2008). TNFα is also 
produced by the MALT in response to many gastrointestinal pathogens and can 
contribute both to host defence and host damage (Jung et al., 1995). Within the 
MALT, it is important that both IECs and macrophages are capable of producing 





production in either of these cell types could cause the intestinal epithelium to 
experience an excessive amount of TNFα exposure, greatly increasing basal 
physiological concentrations and contributing to host damage through 
inflammatory responses.  
As mentioned previously, supernatant-based approaches to probiotic 
immunology are now being contrasted with the more traditional approach of 
using whole bacterial cells. However, within both approaches, literature 
concerning the effect of growth phase on the bioactivity of lactic acid bacteria 
and supernatants is uncommon. The development of a functional and 
reproducible growth curve was required to accurately determine the timings for 
log and stationary growth phases of the lactic acid bacteria used in this study 
and to prepare the corresponding spent culture supernatants. 
 
Lactic acid bacteria growth curves and other properties 
 The optical density (O.D.) ranges for each growth phase varied between 
bacterial strains. However, for all strains, the log and stationary phases of growth 
were clearly distinct. Each time period, as determined by O.D. patterns, for every 
strain and growth phase yielded consistent bacterial concentrations and broth 
pH. However, for each Lactobacillus strain the log phase concentrations were 
greater than for strain-respective stationary phase concentrations. Although this 
was not expected, there is a plausible reason for this observation: as bacterial 





to earlier time points. As a result, slight changes in population decreases may be 
represented by increased light absorption at later growth phases. This may also 
be compounded by the fact that the O.D. curves misleadingly appear similar to 
theoretical growth curves. This has been a point of contention in the 
establishment of growth curves for other strains of lactic acid bacteria (Fu and 
Mathews, 1999; Delley and Germond, 2002). 
Since the growth curves were determined on the basis of O.D., as 
opposed to concentration and viability, it is possible that the curve may have 
been misrepresenting the actual growth phases, even if only slightly. At the end 
of a stationary growth phase, populations are expected to plateau, if not begin to 
experience increased mortality as media is depleted of nutrients. Therefore, it is 
possible that the accepted stationary growth phase is actually a plateau or death 
spiral. This could also explain the increased absorbance relative to 
concentration, especially in light of the fact that cells begin to lyse and distribute 
cellular debris as the media is fully consumed. This possibility is further 
strengthened by the fact that other strains of lactic acid bacteria have had the 
end of stationary growth phases established at a period of 16 hours (Haller et al. 
1999), in contrast to the times of 19 hours for the GG stationary phase, and 20 
hours for the RO011 and RO052 strains observed in this study. 
For each strain, the pH of spent broths was always lowest during 
stationary phase. This characteristic was expected for two reasons: First, lactic 
acid bacteria produce lactic acid as a product of their metabolism, which in turn 





Secondly, the greater quantity of lysing cells at stationary phase may release 
numerous other acidic metabolic components into the surrounding media, further 
decreasing pH (De Angelis and Gobbetti, 2004). 
 
Unspent and Spent Broth Effects 
Initially, the intention of the research conducted for this thesis concerned 
the immunomodulatory effects of LAB on a variety of challenges with a focus on 
the effects of whole bacteria. However, in response to studies suggesting 
biological activity in spent culture media (Yan et al., 2007; Coconnier et al., 1992; 
Coconnier et al., 2000) this approach was tested and found to be effective. Initial 
testing of spent culture broths was carried out on the U-937 cell line and 
indicated that RO011 stationary phase broth was most effective at decreasing 
TNFα-induced IL-8 production. Log phase broth from RO011 and log or 
stationary broth from RO052 or L. GG were less effective. 
The same experiment was repeated using the HT-29 IEC line. 
Interestingly, the same pattern of activity was present yet the effects were much 
more striking. TNFα -challenged HT-29 cells displayed a significant decrease in 
IL-8 production when treated with a 1 in 10 dilution of spent, stationary phase 
RO011 MRS broth. 
To determine whether or not the decrease in IL-8 production was a 
consequence of the unique compounds within the spent broth or simply due to a 





These controls were designed to determine whether the decrease in IL-8 
production was genuine or a consequence of a low pH, leading to the death of 
the cell line before any IL-8 could be produced. The acidified controls (prepared 
with either HCl or lactic acid) had no significant effects on IL-8 production in 
either unchallenged or TNFα-challenged cells. The results suggest that the 
observed effects of RO011 stationary phase broth were not due to lactic acid, a 
mediator that has recently been suggested as responsible for inhibition of NF-κB 
activation and IL-8 production in IEC (Kumar et al., 2009).  
Initial testing of spent culture supernatants carried out on U-937 
macrophage cells indicated that supernatants from RO011 stationary phase 
broth were most effective at decreasing TNFα-induced IL-8 production using 
broth at a 1 in 10 dilution. However, a percent-control conversion was used to 
examine the data as the variation in IL-8 production between TNFα challenges 
was high. This appears to be a property of the U-937 response to TNFα, as the 
variation in responses to TNFα was much less pronounced for the HT-29 IEC 
line.  
The same significant decrease in IL-8 production was observed for both 
cell lines after treatment with freeze-dried, spent stationary phase RO011 phase 
broth. For the most part, the IL-8 production was the same among all iterations of 
acidified broth controls. To determine the point at which the freeze-dried, 
stationary phase RO011broth was most effective at decreasing IL-8 production 
under challenge, a dilution gradient was constructed. Interestingly, the IL-8 





by volume was reached. Despite a low IL-8 secretion level, the TNFα-challenged 
cells remained viable beyond the challenge incubation. The broth dilution of 3% 
resulted in IL-8 production return to levels that were not significantly different 
from those of TNFα-challenged control cells. This suggests there is an optimal 
dilution “breakpoint” or threshold level for the immunomodulatory effects of the 
spent RO011 broth. The method of freeze-drying was used to allow for a 
gradient of spent broth concentrations, as well as determine whether or not the 
broth retained its effect after being frozen (Broekaert et al., 2007).  
It is interesting to note that unspent MRS broth increased IL-8 production 
in unchallenged cells. To determine the cause of this effect, the components of 
the broth have to be considered. This effect is particularly perplexing because 
every component of the broth is encountered by human IECs, especially cells 
involved in regular digestion, although this does not apply to the U-937 
monocytes. One possible explanation for this effect would be that the surfactants 
within the broth are irritants to cells, causing a disruption to membrane structure, 
eliciting a pro-inflammatory response. Changes in membrane structure and 
exposure to various irritants have been shown to prolong NF-κB nuclear 
localization, and this effect could be present when cells experience unspent MRS 
broth (Enesa et al., 2008). However, as these compounds catabolize during 
bacterial metabolic processes, the effect is not present in spent broth. 
Another point of interest is the significant increase observed in IL-8 
production in challenged HT-29 cells when treated with freeze-dried, stationary 





have been released from lysed bacterial cells, thus leading to NF-κB activation 
and subsequent IL-8 production (Iyer et al., 2008). This was the only time any 
LAB or LAB-based supernatant-product was seen to significantly increase IL-8 
levels above challenge-control values. However, this was only observed once 
with one sample of RO011 broth, it is possibly an aberration. Further comparison 
of bacteria and broth effects will help clarify this. 
Although the GM-CSF assays yielded very little information in the HT-29 
cell line responses to spent-culture broth treatments, the ability of this cell line to 
produce GM-CSF has been documented before, albeit under the influence of 
another challenge type (Long et al., 2001). However, as the level of GM-CSF 
induced in our system was below the level of detection, this analysis was not 
pursued further. 
Although much remains to be determined regarding the underlying cause 
of the immunomodulatory effect of spent broth, they are highly suggestive that 
RO011 releases an active component from the cell into the culture media. This is 
in agreement with some of the most recent studies examining LAB-derived 









Table 5. Summary of the current literature concerning the immunomodulatory 
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The immunomodulatory effects of viable LAB were also examined, 
especially in light of the increase in HT-29 IL-8 production observed following 
treatment with freeze-dried, stationary phase RO011 bacteria. The 3 strains 
tested had no statistically significant effects on IL-8 production by either HT-29 or 
U-937 cell lines, unchallenged or TNFα-challenged. When results were analyzed 
as a percent-control, in order to normalize variation in responses to TNFα, the 
effects of stationary phase RO052 on IL-8 production by TNFα-challenged HT-29 
cells approaches a trend toward statistical significance. This could suggest that 
RO052 is more effective when whole cells are in contact with HT-29 IEC, rather 
than mediating effects through a released component, in contrast to the RO011 
strain. This would also be in keeping with the current literature evaluating the 
immunomodulatory effects of LAB on IL-8 production in a variety of cell lines as 
some strains have been reported to be effective only when whole viable cells are 
tested, while others have been reported to produce biologically active 










Table 6. Summary of current literature concerning the immunomodulatory 
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Work in Progress and Future Directions 
 The work contained within this thesis has branched off into several, 
related endeavours. The first branch concerns improving knowledge of the 
properties of the L. rhamnosus RO011 component in spent culture broth. 
Currently, freeze-dried stationary phase broth from RO011 is being tested to 
determine the nature of the biologically active component responsible for the 
decrease in IL-8 production by TNFα-challenged HT-29 IEC and U-937 
monocytes.   
The second branch of work in progress concerns characterization of the 
range of immunomodulatory activity of the RO011 stationary phase broth 
components by expanding both the range of challenges used and the range of 
parameters measured. The main focus of this research will revolve around 
determining whether other biomarkers of inflammation and activation are 
influenced by strain RO011. The impact on cell-surface molecule expression is 
also being evaluated, focusing on surface markers related to co-stimulatory 
activity (CD80 and CD86) and strengthened adhesion in professional APC’s 
(CD58-CD2 junction) (Ebert et al., 2009). The basis for this is not only to 
evaluate the immunomodulation of cells by LAB through this pathway, but also 
as a means of comparing the involvement of this form of signaling between two 
distinct cell types. 
 Characterizations of the effects on the same cell lines under a variety of 





pathways induced by other cytokines (Beaurepaire et al., 2009). Effects on gene 
expression of pro-inflammatory biomarkers is also being established to 
complement the secretory-level protein quantification in an attempt to provide a 
more holistic understanding of the underlying mechanisms involved in 
immunomodulation and bacterial cross-talk, as suggested by the results of by Li 
et al. (1998). 
 Evaluating the effect of these LAB strains and their respective spent 
culture broths on apoptosis induction is also a relevant future direction, as anti-
apoptotic activity of peptides produced by L. rhamnosus GG has been reported, 
especially in the wake of pro-apoptotic TNFα effects (Yan et al., 2007; Iyer et al., 
2008) 
 This research can be carried further into numerous directions. As a field, 
there are many underlying issues which must be resolved before a complete 
understanding of the role of probiotics in immunology can be reached. For 
example, further elucidation of the kinetics and dynamics of NF-κB mechanism 
will assist the current understanding of cellular responses to autoimmune and 
pathogenic challenges. Breakthroughs in the field of pure immunology are poised 
to benefit fields of applied immunology, especially probiotic research. 
 Although there are many questions that must still be answered using the 
current in vitro model, the next logical step in advancing the experiments outlined 
in this thesis would be to investigate the applicability of co-culture studies. Co-





in further evaluating such measures as the IL-8 macrophage recruitment ability 
of intestinal epithelial cells (Haller et al., 2000).  
Effects of lactic acid bacteria on measures of macrophage and IEC 
activity, including phagocytosis, oxidative burst and nitric oxide production 
assays could be observed upon treating HT-29 IECs with U-937 monocytic cells 
post-challenge and LAB (broth or bacteria) treatment. Examining the effect of the 
LAB on macrophage activity in the presence of HT-29 could provide insight 
towards how the LAB is immunomodulating any cell-cell interaction. Also, if two 
challenges were separately used, one pathogenic (such as LPS) and the other 
endogenous (TNFα) – both strong inducers of the NF-κB pathway - the 
aforementioned assays could be useful in helping establish whether or not LAB 
are more useful in enhancing immunity in response to a pathogen. Other 
pathogenic challenges could also be utilized in the future, such as soluble egg 
antigens from parasites known to infect the human gastrointestinal tract (van 
Liempt, 2007). 
 In the practical sense, the knowledge obtained from gains in the 
understanding of commensal and probiotic bacteria will help create healthier, 
improved foods with longer shelf lives and, ultimately, improved health and 
disease prevention (Champagne et al., 2009; Resta-Lenert and Barrett, 2006; 
2009). Unfortunately, due to the fact that the composition of the intestinal 
microflora is quite varied between individuals from different environments and 
habitats, the potential applications of probiotics remain controversial and much 





(Denou et al., 2008). A proposed solution to this dilemma could lie in in situ 
global assays of host gene expression correlated with microflora composition. 
Although such a process would be many years in the making, it is not unrealistic 
to believe this type of diagnostic technology is on the horizon because the 
framework is already taking shape (Denou et al., 2008). 
 
Conclusion 
This work further characterized immunomodulatory effects of 3 strains of 
lactic acid bacteria. L. rhamnosus RO011 was found to have growth phase-
dependent effects on two different cell types involved in innate immunity (IECs 
and monocytes). These effects appear to be mediated by a component released 
by L. rhamnosus RO011 unto spent culture medium. Although the underlying 
mechanisms responsible for the observed effects require more investigation and 
observation, these results are in keeping with current models for bioactivity of 
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